Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

astrazeneca

An illustrative image of a person holding a medical syringe and a vaccine vial in front of the AstraZeneca logo on October 21, 2021 in Edmonton, Alberta, Canada. (Photo: Artur Widak/NurPhoto via Getty Images)

Why Is This Pandemic Taking So Long? In One Word: Greed

The longer it takes the world to get vaccinated, the more variants we'll see.

Peter Certo

 by OtherWords

Stop me if this sounds familiar.

It's been kind of a hard year, but I felt optimistic about the holidays. My wife and I had just scheduled our COVID-19 boosters. Even better, we'd been able to get our young child vaccinated.

We imagined a cautious return to simple family pleasures like indoor dining—and maybe playdates at indoor play centers during the long Midwestern winter. Maybe we'd even test our kid's appetite for air travel and visit relatives in different parts of the country.

Then—another COVID-19 variant. Possible breakthrough infections. Travel bans and tumbling stock markets. And that familiar feeling of the rug being pulled out.

Vaccine equity could save millions of lives and prevent needless suffering.

We don't know a whole lot about the Omicron variant yet. Will it fizzle out like earlier variants, or run rampant like Delta? Whatever happens, we do know one thing: The longer it takes the world to get vaccinated, the more variants we'll see.

Here in the United States, getting vaccination rates up means battling misinformation, apathy, and employers who won't give their employees sick time. But vaccinating the rest of the world means battling corporate greed.

In poorer countries, vaccine access is limited by the patent protections for pharmaceutical giants like Pfizer, Modern, and Johnson & Johnson. That puts life-saving vaccines beyond the reach of what many countries can comfortably afford.

Omicron was first reported in South Africa. As my Institute for Policy Studies colleagues pointed out in their invaluable Inequality.org newsletter, "South Africa had pleaded with Western governments earlier this year to waive vaccine patents. Instead, South Africa ended up having to pay over double the price for doses that European Union nations paid."

Thanks to price gouging like that, they note, Moderna alone has minted five new billionaires. Meanwhile South Africa's vaccination rate hovers at less than 30 percent. With rates that low, new variants are inevitable.

But South Africa is comparatively lucky—less than 10 percent of people on the African continent are fully vaccinated.

According to the People's Vaccine Alliance, rich countries have received about 50 times as many vaccine doses as poor countries. That means the virus has free rein to multiply over vast swathes of the planet. Every new infection increases the possibility of new variants—including some that may prove resistant to the existing vaccines.

To close those gaps, poorer countries need more vaccines—and fast.

The Biden administration courageously defied Big Pharma by backing a waiver for vaccine patents. But countries like Germany continue to resist it, and advocates insist the U.S. isn't doing enough to fight for it.

Another solution involves simply sending doses overseas. The administration announced in August it had already exported 110 million doses, and it recently promised another 500 million. That's good, but public health advocates are calling for far more.

Vaccine equity could save millions of lives and prevent needless suffering. That's reason enough on its own.

But by protecting workers across the globe, it would also ease the global supply disruptions that are contributing to inflation here and abroad. And it would go a long way toward ensuring that the existing vaccines remain effective.

"You may be fully vaccinated, you may have had your booster, but you're not that disconnected from the person who lives in a country where only 2 percent of the population is vaccinated,"warns Emory University virologist Boghuma Kabisen Titanji.

If these gaps persist, "the virus will catch up with us regardless of where you are."

She's right. Thanks to a new variant halfway around the world, I have to worry about whether I can take my kid to the diner down the road. But it's a fitting holiday lesson, in a way—the more we give, the more we get. Better tell the administration to make a list.


This work is licensed under a Creative Commons Attribution-Share Alike 3.0 License.
Peter Certo

Peter Certo

Peter Certo is the Institute for Policy Studies (IPS) editorial manager.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Buddhist Monk and Peace Activist Thích Nhất Hạnh Dead at 95

"He inspired so many good people to dedicate themselves to working for a more just and compassionate world."

Jessica Corbett ·


Draft Order Shows Trump Considered Using Military to Seize Voting Machines

"This was part of the records that Trump was fighting to keep from the January 6th committee," one government watchdog noted.

Brett Wilkins ·


Groups Warn US Lawmakers Against Fueling 'New Cold War' With China

A policy of hostility toward Beijing, says a global justice advocate, has "become a convenient excuse for pushing a corporate, militarist agenda."

Jessica Corbett ·


Democracy 'On the Line' Says Bowman After Protest Arrest

"I will not stand by and I will not stay quiet while the fate of our democracy continues to hang loosely by a thread that the Senate is hellbent on tearing apart."

Julia Conley ·


To 'Hold Her Accountable for What She Did,' Primary Sinema Project Gets Into Gear

"Kyrsten Sinema is unfit to be a United States senator," the project asserts. "Just like the filibuster itself, we need to get rid of her if we want to save our democracy before it's too late."

Brett Wilkins ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo